About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Mycoses
›
top-articles
Mycoses
4.9
(top 5%)
impact factor
6.8K
(top 5%)
papers
91.9K
(top 5%)
citations
94
(top 5%)
h
-index
5.1
(top 10%)
extended IF
8.8K
all documents
100.5K
doc citations
136
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Epidemiological trends in skin mycoses worldwide
Mycoses
2008
970
2
Molecular diagnostics of clinical strains of filamentous Basidiomycetes
Mycoses
1998
492
3
COVID‐19 associated pulmonary aspergillosis
Mycoses
2020
452
4
Hydrolytic enzymes as virulence factors of Candida albicans
Mycoses
2005
432
5
The changing face of epidemiology of invasive fungal disease in Europe
Mycoses
2009
359
6
The Clinical Pharmacokinetics of Itraconazole: An Overview
Mycoses
1989
346
7
Antifungal drug resistance among
Candida
species: mechanisms and clinical impact
Mycoses
2015
332
8
High terbinafine resistance in
Trichophyton interdigitale
isolates in Delhi, India harbouring mutations in the squalene epoxidase gene
Mycoses
2018
256
9
An outbreak due to
Candida auris
with prolonged colonisation and candidaemia in a tertiary care European hospital
Mycoses
2018
254
10
Trichosporon on humans: a practical account
Mycoses
1994
248
11
Antifungal activity of plant extracts against dermatophytes
Mycoses
1999
229
12
Aspergillus flavus
: an emerging non‐
fumigatus Aspergillus
species of significance
Mycoses
2009
227
13
Epidemiology of tinea capitis in Europe: current state and changing patterns
Mycoses
2007
224
14
Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum
Mycoses
1989
212
15
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study
Mycoses
2013
205
16
Chromoblastomycosis: clinical and mycologic experience of 51 cases
Mycoses
2001
199
17
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Mycoses
2021
195
18
Mucormycoses
Mycoses
2001
178
19
The current Indian epidemic of superficial dermatophytosis due to
Trichophyton mentagrophytes
—A molecular study
Mycoses
2019
178
20
Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels
Mycoses
1989
174
21
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis
Mycoses
2003
170
22
In vitro efficacy of 75 essential oils against Aspergillus niger
Mycoses
2006
170
23
Histoplasmosis: a review for clinicians from non-endemic areas
Mycoses
2006
166
24
In vitro antimicrobial activity of olive leaves. Antimikrobielle Wirksamkeit von Olivenblattern in vitro
Mycoses
2003
164
25
High prevalence of foot diseases in Europe: results of the Achilles Project
Mycoses
2003
163
26
Fungal keratitis: An overview of clinical and laboratory aspects
Mycoses
2018
162
27
Mucormycosis in India: unique features
Mycoses
2014
159
28
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis
Mycoses
2021
157
29
Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity
Mycoses
2021
155
30
Candida auris
—the growing menace to global health
Mycoses
2019
153
31
Phospholipase and protease activities in clinical
Candida
isolates with reference to the sources of strains
Mycoses
2002
152
32
A More Sophisticated Method of Determining the Fungicidal Effect of Water‐Insoluble Preparations with a Cell Harvester, Using Miconazole as an Example./Eine verbesserte Methode zur Bestimmung der Fungizidie von wasserunlöslichen Präparaten mit Hilfe eines Zellerntegerätes am Beispiel von Miconazol
Mycoses
1988
152
33
Antifungal activity of propolis on different species ofCandida
Mycoses
2001
151
34
Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis. Verwendung von Punica granatum als Antimykotikum gegen Candidose in Verbindung mit Zahnprothesen-Stomatitis
Mycoses
2003
148
35
Addition of DNase improves the
in vitro
activity of antifungal drugs against
Candida albicans
biofilms
Mycoses
2012
148
36
Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival
Mycoses
1999
147
37
Epidemiology and molecular mechanisms of antifungal resistance in
Candida
and
Aspergillus
Mycoses
2016
147
38
COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan
Mycoses
2020
147
39
Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: A multicentre study
Mycoses
2020
147
40
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
Mycoses
2021
147
41
High prevalence of the neurotropeExophiala dermatitidisand related oligotrophic black yeasts in sauna facilities
Mycoses
2002
145
42
Detection of
Aspergillus
galactomannan antigen in foods and antibiotics
Mycoses
1997
143
43
Dematiaceous fungi
Mycoses
2007
143
44
Inhibitory effect of essential oils on apical growth of Aspergillus fumigatus by vapour contact
Mycoses
2000
142
45
Antifungal susceptibility of
Candida albicans
in biofilms
Mycoses
2012
141
46
Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole
Mycoses
1999
140
47
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice
Mycoses
2005
139
48
The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 ‐ 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studie (1982 ‐ 1987)
Mycoses
1988
139
49
Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
Mycoses
2019
139
50
Performance of
MALDI
‐
TOF MS
platforms for fungal identification
Mycoses
2016
137
site/software ©
exaly
; All materials licenced under
CC by-SA
.